Measures to curb 'unethical profiteering' by private hospitals not working: Govt report

Patients and health groups asserted that the unethical practices of private hospitals are a direct outcome of the regulatory vacuum

FOLLOW UP

Deadly havens

SOUTH AFRICA

Ethically sound

Fat-finding mission

On-off switch for fat formation identified

A palliative gesture

Cochrane library's database not an unequivocal blessing

Beating the cholera bug

Ranbaxy settles patent row out of court

Not the morning after remedy

Overuse of emergency contraceptives can kill

Cry the beloved country

The fight against AIDS in Africa hinges largely on drugs becoming more affordable in poor nations

Indian scientists resurrect World War-era drug to fight malaria

Now, they are working to make this drug more effective using nanotechnology

Poor quality drugs make treatment of ringworm infection less effective

Doctors from Dr Ram Manohar Lohia Hospital found quality issues in the Itraconazole drug

Illegal drug trial in Rajasthan: Why are poor treated as guinea pigs, ask rights groups

They demand thorough probe into unethical trial in Jaipur’s Malpani Hospital and similar such trials in other hospitals across the country

At least 28 Rajasthan villagers duped into being a part of illegal drug trials; probe ordered

After they were drug-tested, they became sick and reported symptoms like dizziness, loss of consciousness, nausea and inability to urinate

India continues to export substandard drugs; lack of regulations real problem: WHO

The WHO report suggests that India is a major player in counterfeit pharmaceutical manufacturing as the country is the world’s largest …

Scientists find new way to improve efficacy of TB treatment

The new add-on therapy consists of injecting ‘heat-killed’ bacteria into patients along with standard TB drugs

Guinea pig out, computer in

Computer-based methods can accurately predict drug side-effects

Double standards

The US government procures generic drugs for anthrax from a non-patent holder

A bitter dose

Multinational drug firms gang up against a company that wants to produce cheaper generics

Sans safeguards?

The newly amended patents bill is replete with loopholes

Cheaper remedy

Novartis loses patent battle

Profit at any cost

The US drug companies want to maintain its monopoly over drug pricing -- a move that will delay the production of cheaper drugs